Page last updated: 2024-10-20

uric acid and EHS Tumor

uric acid has been researched along with EHS Tumor in 2 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WU, C1
BAUER, JM1
Schroeder, HA1
Mitchener, M1
Nason, AP1

Other Studies

2 other studies available for uric acid and EHS Tumor

ArticleYear
Catabolism of xanthine and uracil in tumor-bearing rats.
    Cancer research, 1962, Volume: 22

    Topics: Animals; Carcinoma 256, Walker; Carcinoma, Hepatocellular; Hydantoins; Liver Neoplasms; Neoplasms; N

1962
Life-term effects of nickel in rats: survival, tumors, interactions with trace elements and tissue levels.
    The Journal of nutrition, 1974, Volume: 104, Issue:2

    Topics: Animals; Body Weight; Chromium; Copper; Female; Kidney; Liver; Longevity; Lung; Lymphoma; Male; Mang

1974